| | | | | |
PINE Alpine Income Property Trust, Inc | €18,0339 | +0,05% | €305,99M | €159,00K | |
HCMA HCM III Acquisition Corp. Class A Ordinary Share | €9,0688 | +0,28% | €305,35M | €5,278 | |
HIO Western Asset High Income Opportunity Fund, Inc. | €3,0965 | +0,00% | €305,35M | €851,06K | |
XFOR X4 Pharmaceuticals, Inc. Common Stock | €3,3956 | +0,26% | €305,34M | €441,20K | |
MCI Barings Corporate Investors | €14,5590 | +0,00% | €305,23M | €16,68K | |
BLZR Trailblazer Acquisition Corp. Class A Ordinary Shares | €8,9158 | +0,00% | €305,11M | €293,81 | |
AEF abrdn Emerging Markets ex-China Fund, Inc. | €7,5478 | +0,00% | €304,66M | €73,12K | |
IPFX Inflection Point Acquisition Corp. VI Class A Ordinary Shares | €8,9026 | +0,05% | €304,46M | €23,52K | |
MRLN Merlin, Inc. Common Stock | €3,0790 | +0,87% | €303,98M | €779,77K | |
DSAC Daedalus Special Acquisition Corp. Class A Ordinary Shares | €8,9378 | +0,00% | €303,89M | €311,90K | |
SORN Soren Acquisition Corp. Class A Ordinary Shares | €8,7741 | +0,14% | €303,10M | €88,39K | |
HPF John Hancock Preferred Income Fund II | €13,8641 | +0,00% | €303,02M | €17,82K | |
CZFS Citizens Financial Services, Inc. Common Stock | €65,8104 | -0,09% | €302,56M | €11,04K | |
FENC Fennec Pharmaceuticals Inc. Common Stock | €8,7706 | -0,20% | €302,52M | €60,65K | |
AKBA Akebia Therapeutics, Inc. | €1,0776 | +0,41% | €302,06M | €1,10M | |